Brought to you by the International Journal of Pharmaceutical Compounding FREE TRIAL    FORMULATIONS    MY ACCOUNT 
Compounding This Week Newsletter from www.CompoundingToday.com
Our Compounding Knowledge, Your Peace of Mind
July 19, 2019  |  Volume 16  |  Issue 29
IN THIS ISSUE
 
SUBSCRIPTIONS / INFO
 
CLASSIFIEDS
 
ABOUT COMPOUNDINGTODAY
 
FREE RESOURCES
 
SUBSCRIBER RESOURCES
Become a Board-Certified Sterile Compounding Pharmacist
 
IJPC: Click or Email for Free Sample
Q.I. Medical - Your <797> Compliance Resource
 
Loyd V. Allen, Jr., Ph.d., R.Ph Letter from the Editor
Pharmaceutical Compounding Questions and Answers

Question: Bracketed Stability studies…What are they and can they be used in compounding for stability studies? (Part II)

Answer:
Last week, we presented information about a very simple bracketed stability study that involved only two variables (strength and batch number). This week, we will present a table for a bracketed stability study that is somewhat more complex, which includes a third variable (in this example, package size).

Three Strengths: (50 mg, 75 mg, and 100 mg)
Three Package Sizes: (15 mL, 100 mL, and 150 mL)
Three Batches of Each Strength: (B)

Strength 50 mg 75 mg 100 mg
Batch (B) B1 B2 B3 B1 B2 B3 B1 B2 B3
Package Size
50 mL T T T – – – T T T
100 mL – – – – – – – – –
150 mL T T T – – – T T T

“T� = Tested; “–� = Not Tested

The rationale for bracketing can include the following:

1. Interpolation between extremes is logical.
2. There is no need for the stability to be the same.
3. Savings (e.g., personnel, time, testing).

The issues against bracketing include the following:

1. Some preparations/products and their packaging may be dropped.
2. There is a potential for additions outside of the “bracket.�

Concerning “bracketing,� what is justified and what is not? Below is a brief summary:

  • Strengths of identical or closely related formulations can be bracketed without further justification.
  • Relative amounts of drug substances and excipient changes in a formulation can be bracketed with justification.
However, one cannot use bracketing with different excipients with different strengths.

Continued next week

REMINDER: For those State Boards of Pharmacy that are not adopting the USP chapters and are preparing their own or using their own modifications of the chapters, easily-modifiable alternative versions of Chapters <795>, <797>, and <800> have been prepared and are available as a free download for use by state boards of pharmacy to modify for their individual states at the following website.

      CompoundingToday.com

Pharmacists may wish to download and send to your state board of pharmacy for consideration.


Loyd V. Allen, Jr., PhD, RPh
Editor-in-Chief

International Journal of Pharmaceutical Compounding
Remington: The Science and Practice of Pharmacy Twenty-second edition

Did you know that the new USP <797> BUD standards not allowing extended stability will effectively eliminate the usefulness of ALL published and nonpublished stability studies for BUDS in:

Trissel’s Handbook of Injectable Drugs
King Guide to Parenteral Admixtures
CompoundingToday.com
International Journal of Pharmaceutical Compounding
American Journal of Health-System Pharmacists
Annals of Pharmacotherapy
Pharmaceutical science journals containing stability studies:
     Journal of Pharmaceutical Sciences
     AAPS Pharmaceutical Sciences
     International Journal of Pharmaceutics
     Many others
Pharmaceutical compounding supply companies and pharmaceutical companies (PHARMA) that have funded and conducted hundreds of stability studies utilizing their drug substances and vehicles.

In summary, the monetary value is in the millions of dollars of data that will now be USELESS!

This poses a financial hardship on all those involved for no valid, justifiable, scientifically-based reason.

Note: A Sterile Compounding Consensus Statement representing a digest of important changes found in the recently published final version of USP Chapter <797> has just been released, and is available on the Compounding Today website at: CompoundingToday.com

All sterile compounders and their allies are encouraged to download and read this concise summary, which includes a number of candid critiques concerning the chapter. Readers are also encouraged to share it or the link to it far and wide – including with their state boards of pharmacy and various organizations.

As USP must rely upon state boards of pharmacy for enforcement of <797>, perhaps these entities can be persuaded to refrain from doing so regarding some more controversial elements of the chapter.

           Sterile Compounding Consensus Group (SCCG)

 

Did You Know ...

...that regarding Common Sense (CS), E. Hubbard (The Note Book, 1927) said that “Logic is one thing and CS is another?

CS is…

…the ability to detect values.
...the knack of seeing things as they are, and doing things as they ought to be done. (E.C. Stowe)
...an uncommon degree in what the world calls wisdom. (S.T. Coleridge)

 

IJPC Now on Facebook and Youtube

Become a fan of the IJPC Facebook page and share ideas, photos, and keep up to date with the latest compounding information - http://www.facebook.com/IJPCompounding

View our growing collection of educational and training videos at www.ijpc.com/video or by subscribing to our Youtube channel at https://www.youtube.com/IJPCompounding.

 

Looking Back

The crowd you see,
Around the store,
Are Burma-Shavers,
Buying more!
     Burma-Shave

Copyright 2019
International Journal of Pharmaceutical Compounding, Inc.
122 N Bryant Ave, Edmond OK 73034
Manage my Email:
Subscribe / Un-Subscribe
Comments or Questions:
info@compoundingtoday.com
Reprints & Permissions: Reprints@ijpc.com